Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INS365 Rising-Dose Study in Dry Eye Disease
NCT00680108Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Sep 1999
- Primary completion
- May 2000
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of diquafosol in dry eye disease (DED), sponsored by Merck & Co.. Started Sep 1999; status: completed.
02
Drugs
diquafosol
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT00680108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00680108.